Regeneus Ltd's (ASX:RGS) Leo Lee speaks to Proactive's Andrew Scott while at the virtual ASX Small and Mid-Cap Conference 2020. They're an Australian biotech looking to improve the quality of life for patients suffering from pain. It develops regenerative medicine products that interrupt the inflammatory cascade that leads to pain.
Regeneus Ltd with Proactive at the ASX Small and Mid-Cap Conference 2020
Quick facts: Regeneus Ltd
Price: 0.17 AUD
Market Cap: $51.05 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE